Parliament Votes to Support Global Health R&D

Source DSW

The European Parliament’s Industry, Research and Energy Committee (ITRE) voted today on the new research and innovation framework programme Horizon 2020 which will start in 2014.  The new seven-year Horizon 2020 funding programme will replace the FP7 programme (the Seventh Framework Programme for Research and Technological Development) which runs until 2013.

Investing in Global Health R&D: Is it worth it?

(L) Dr. Line Matthiesen, DG Research & Innovation, European Commission

MEP Maria Da Graça Carvalho, member of ITRE (Industry, Research & Energy Committee)

(R) Karen Hoehn, Vice Executive Director and Director of International Affairs, DSW

Sustainability Consult attended a study launch event (‘EU Return on Investments in Global Health R&D’) at the European Parliament on Wednesday 26 September.  Hosted by MEP Maria Da Graça Carvalho, the launch panel included representatives of the European pharmaceutical industry, such as GlaxoSmithKline’s VP for Government Affairs Jon Pender, academia, such as Professor Bruno Gryseels, Director of the Institute of Tropical Medecine at Antwerp, Dr. Line Matthiessen from the European Commission’s Directorate-General for Research & Innovation and NGOs such as Chris Wilson of the Bill & Melinda Gates Foundation.